Annual Report

Overview

The report presents Sun Pharma's FY2025-26 consolidated revenue from operations of 584,620.4 ₹ Million, alongside a 35% absolute Scope 1 and Scope 2 reduction target for 2030 from a 2020 baseline. It reports 52.55% renewable energy in the BRSR and reproduces DNV's assurance statement, including reasonable assurance over BRSR Core KPIs and limited assurance over other selected indicators.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025-2026
Period: 1 April 2025 – 31 March 2026
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services